GTC
AMAG

Ghost Tree Capital’s AMAG Pharmaceuticals AMAG Stock Holding History

Ghost Tree Capital’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-80,000
Closed -$3.41M – 85
2014
Q4 		$3.41M Buy
+80,000
New +$2.89M 1.64% 27
2014
Q3 		– Sell
-100,000
Closed -$2.07M – 87
2014
Q2 		$2.07M Sell
100,000
-92,057
-48% -$1.7M 1.46% 27
2014
Q1 		$3.72M Buy
+192,057
New +$4.08M 2.21% 14

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ghost Tree Capital's AMAG Position: Q1 2015 in Review

Ghost Tree Capital sold out of AMAG Pharmaceuticals (AMAG) in Q1 2015, closing a stake of 80,000 shares — an estimated $3.41M sold.

Ghost Tree Capital first reported a position in AMAG in Q1 2014 and held it in 3 quarters. The position peaked at $3.72M in Q1 2014. 197 funds tracked by Wall St. Rank hold AMAG as of Q1 2015.

  • Ghost Tree Capital reported no remaining AMAG Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Ghost Tree Capital sold 80,000 AMAG Pharmaceuticals shares in Q1 2015, an estimated $3.41M.
  • Ghost Tree Capital first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 3 quarters.
  • Ghost Tree Capital's AMAG Pharmaceuticals position peaked at $3.72M in Q1 2014.
  • 197 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2015.

Based on Ghost Tree Capital's 13F filing for Q1 2015, filed 15 May 2015.